• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化急性加重预测模型的开发:韩国特发性肺纤维化队列登记研究

Development of a Prediction Model for Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Study of the Korea IPF Cohort Registry.

作者信息

Lee Jae Ha, Jang Ji Hoon, Kim Song Yee, Park Moo Suk, Chung Man Pyo, Yoo Hongseok, Jeong Sung Hwan, Lee Hong Lyeol, Choi Sun Mi, Kim Young Whan, Kim Yong Hyun, Park Sung Woo, Park Jong Sun, Jegal Yangjin, Jo Yong Suk, Yoon Hee-Young, Kim Tae-Hyung, Kim Yee Hyung, Shin Beomsu, Lee Hyun-Kyung, Yang Sei-Hoon, Lee Hyun, Kim Sang-Heon, Lee Eun Joo, Choi Hye Sook, Kang Hyung Koo, Heo Eun Young, Lee Won-Yeon, Song Jin Woo

机构信息

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2025 Sep 1;40(34):e212. doi: 10.3346/jkms.2025.40.e212.

DOI:10.3346/jkms.2025.40.e212
PMID:40891160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401742/
Abstract

BACKGROUND

Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) has the most disastrous impact on prognosis as a major cause of morbidity and mortality. However, there is no proven treatment, and the occurrence of AE is unpredictable. This study aimed to develop a prediction model for AE in patients with IPF using the nationwide Korea IPF Cohort (KICO) registry.

METHODS

This is a retrospective study of Korean patients with IPF who were enrolled from June 2016 to February 2022 in the KICO registry. We developed a prediction model for AE based on risk factors found in the multivariable logistic regression model.

RESULTS

Of 678 patients with IPF, the mean age was 69.4 years, and 82.0% were male. AE occurred in 165 patients (24.3%) during follow-up (median: 40.7 months). The median time from IPF diagnosis to AE was 11.6 (interquartile range: 3.6-23.5) months. Lower forced vital capacity (FVC), shorter six-minute walking distance (6MWD), and the use of home oxygen were independently associated with AE in the multivariable logistic analysis. In a risk-predicting model using variables of FVC, 6MWD, and the use of home oxygen, there was a significant predictive power for AE in both score (area under the curve [AUC], 0.746; 95% confidence interval [CI], 0.705-0.783; < 0.001) and stage (AUC, 0.696; 95% CI, 0.654-0.736; < 0.001).

CONCLUSION

Our results suggest that a model using FVC, 6MWD, and home oxygen use may be useful in predicting AE in patients with IPF.

摘要

背景

特发性肺纤维化(IPF)的急性加重(AE)作为发病和死亡的主要原因,对预后具有最灾难性的影响。然而,目前尚无经证实的治疗方法,且AE的发生不可预测。本研究旨在利用韩国全国IPF队列(KICO)登记处的数据,开发一种IPF患者AE的预测模型。

方法

这是一项对2016年6月至2022年2月纳入KICO登记处的韩国IPF患者的回顾性研究。我们基于多变量逻辑回归模型中发现的危险因素,开发了一种AE的预测模型。

结果

678例IPF患者的平均年龄为69.4岁,82.0%为男性。随访期间,165例患者(24.3%)发生了AE(中位时间:40.7个月)。从IPF诊断到AE的中位时间为11.6(四分位间距:3.6 - 23.5)个月。在多变量逻辑分析中,较低的用力肺活量(FVC)、较短的6分钟步行距离(6MWD)以及家庭氧疗的使用与AE独立相关。在使用FVC、6MWD和家庭氧疗使用变量的风险预测模型中,评分(曲线下面积[AUC],0.746;95%置信区间[CI],0.705 - 0.783;P < 0.001)和分期(AUC,0.696;95% CI,0.654 - 0.736;P < 0.001)对AE均具有显著的预测能力。

结论

我们的结果表明,使用FVC、6MWD和家庭氧疗使用情况的模型可能有助于预测IPF患者的AE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/935f/12401742/3d796b8e930a/jkms-40-e212-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/935f/12401742/c3b49bc706c4/jkms-40-e212-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/935f/12401742/3d796b8e930a/jkms-40-e212-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/935f/12401742/c3b49bc706c4/jkms-40-e212-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/935f/12401742/3d796b8e930a/jkms-40-e212-g002.jpg

相似文献

1
Development of a Prediction Model for Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Study of the Korea IPF Cohort Registry.特发性肺纤维化急性加重预测模型的开发:韩国特发性肺纤维化队列登记研究
J Korean Med Sci. 2025 Sep 1;40(34):e212. doi: 10.3346/jkms.2025.40.e212.
2
Pulmonary rehabilitation for interstitial lung disease.间质性肺疾病的肺康复治疗。
Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4.
3
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.长期暴露于空气污染与特发性肺纤维化的严重程度:来自特发性肺纤维化前瞻性结局(IPF-PRO)注册研究的数据。
Ann Am Thorac Soc. 2025 Mar;22(3):378-386. doi: 10.1513/AnnalsATS.202404-382OC.
4
Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial.金贝口服液治疗特发性肺纤维化:一项随机安慰剂对照试验
Sci Rep. 2025 Jan 23;15(1):3007. doi: 10.1038/s41598-025-87474-x.
5
Efficacy and Safety of Nintedanib in Japanese Patients With Early-Stage Idiopathic Pulmonary Fibrosis: A One-Year Interim Analysis from a Multicenter Observational Study in Kyushu and Okinawa, Japan.尼达尼布治疗日本早期特发性肺纤维化患者的疗效和安全性:来自日本九州和冲绳多中心观察性研究的一年期中分析
Clin Ther. 2025 Aug;47(8):587-594. doi: 10.1016/j.clinthera.2025.05.007. Epub 2025 Jun 6.
6
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
9
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.特发性肺纤维化急性加重的危险因素:一项系统评价和荟萃分析。
Clin Respir J. 2018 Mar;12(3):1084-1092. doi: 10.1111/crj.12631. Epub 2017 Apr 12.
10
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.

本文引用的文献

1
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.特发性肺纤维化(IPF)或非特发性间质性肺炎患者的生存和急性加重:前瞻性多机构患者登记的 5 年随访分析。
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001864.
2
Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis.特发性肺纤维化和特发性胸膜肺实质纤维弹性组织增生症中六分钟步行距离的决定因素
Biomedicines. 2022 Oct 13;10(10):2556. doi: 10.3390/biomedicines10102556.
3
Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
日本特发性肺纤维化急性加重症的治疗发生率和变化:一项基于理赔的回顾性研究。
Respir Investig. 2022 Nov;60(6):798-805. doi: 10.1016/j.resinv.2022.07.004. Epub 2022 Sep 5.
4
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
5
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis.一个简单的多维指数的推导和验证,纳入运动能力参数,用于特发性肺纤维化的生存预测。
Thorax. 2023 Apr;78(4):368-375. doi: 10.1136/thoraxjnl-2021-218440. Epub 2022 Mar 24.
6
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.抗纤维化治疗对特发性肺纤维化死亡率和急性加重的影响:系统评价和荟萃分析。
Chest. 2021 Nov;160(5):1751-1763. doi: 10.1016/j.chest.2021.06.049. Epub 2021 Jul 2.
7
Acute exacerbation in interstitial lung disease.间质性肺疾病急性加重
Ann Thorac Med. 2021 Apr-Jun;16(2):178-187. doi: 10.4103/atm.atm_14_21. Epub 2021 Apr 17.
8
A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者急性加重风险预测的临床模型。
Biomed Res Int. 2020 Dec 7;2020:8848919. doi: 10.1155/2020/8848919. eCollection 2020.
9
Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的预后因素的系统评价和荟萃分析。
BMJ Open. 2020 Jun 15;10(6):e035420. doi: 10.1136/bmjopen-2019-035420.
10
Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.经手术证实为普通型间质性肺炎的特发性肺纤维化新定义急性加重:危险因素与预后
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(1):39-46. doi: 10.36141/svdld.v36i1.7117. Epub 2019 May 1.